VEGFA and breast cancer: At the same time, data presented here provided evidence that Oridonin more significantly inhibited VEGF-induced transendothelial migration than that of FBS-induced in breast cancer cell (Fig. 5B), implying that Oridonin has potential specificity for a downstream target of VEGF signaling.